News Johnson & Johnson Deutsche Boerse AG

Equities

JNJ

US4781601046

Market Closed - Deutsche Boerse AG Other stock markets 02:13:27 2024-05-28 pm EDT			After market 04:00:10 pm
132.7 ^EUR	-3.31%		133	+0.18%

09:56pm	Sector Update: Health Care Stocks Fall Late Afternoon	MT
08:02pm	Sector Update: Health Care Stocks Retreat Tuesday Afternoon	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Fall Late Afternoon	03:56pm	MT
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	02:02pm	MT
Sector Update: Health Care	01:43pm	MT
Bio-Thera, Stada Enter Deal for Biosimilar Candidate to Johnson & Johnson's Simponi in EU, UK	01:24pm	MT
Johnson & Johnson Agrees to Buy Numab Unit, Investigational Skin Disease Treatment For $1.25 Billion	12:45pm	MT
Top Midday Stories: Wall Street Returns to T+1 Settlements; T-Mobile Buys US Cellular's Wireless Ops; Energy Transfer Buys WTG Midstream; GameStop Extends Rally	11:56am	MT
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	09:59am	MT
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	09:15am	MT
Johnson & Johnson Acquires Experimental Eczema Drug for $1.25 Billion	09:14am	MT
J&J: acquisition of Swiss eczema biotech company	08:34am	CF
J&J to Acquire Skin Disease Treatment Rights from Numab in $1.25 Billion Deal	08:10am	DJ
J&J acquires rights to skin disorder drug for $1.25 bln	07:37am	RE
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis	07:35am	AQ
Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis	07:32am	BU
Johnson & Johnson: Meet a nurse who leads clinical trials to find innovative cancer therapies	May. 24	AQ
J&J: to present advances at ASCO and EHA	May. 24	CF
Johnson & Johnson : advances leadership in oncology innovation with more than 75 clinical study and real-world presentations at ASCO and EHA	May. 24	PU
Some of the biggest splits in Corporate America	May. 23	RE
Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies	May. 22	RE
Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says	May. 22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST